All Stories

  1. Percutaneous antegrade-retrograde recanalization (rendezvous technique) of a complete ureteropelvic junction disruption after robotic-assisted partial nephrectomy: A case report
  2. Metastatic Testicular Germ Cell Tumor in a Patient With Neurofibromatosis Type 1: Treatment With Trametinib Based on NF1 Gene Mutation
  3. A case of renal primary neuroendocrine tumor (G3) in which 177Lu-PRRT was effective for disease control
  4. Clonal selection of pre-existing neuroendocrine component in prostate cancer during androgen receptor signaling inhibitor therapy: A case report
  5. Successful Emergency Cardiac Surgery for Intraoperative Pulmonary Artery Tumor Embolism During Renal Cell Carcinoma Surgery: A Case Report
  6. ΔBSIJ: a quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents
  7. ΔBSIJ: A quantitative marker for early detection of medication-related osteonecrosis of the jaw in patients with prostate cancer receiving bone-modifying agents
  8. Tertiary Lymphoid Structures Correlate With Better Prognosis in Patients With Retroperitoneal Sarcoma: A Retrospective Study
  9. Cabozantinib for brain metastases in renal cell carcinoma: a single-institution retrospective analysis
  10. ABC Transporters Predict Enfortumab Vedotin Effectiveness in Bladder Cancer Treatment
  11. A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy
  12. Increased expression of ATP‐binding cassette transporters in enfortumab vedotin‐resistant urothelial cancer
  13. Association between Immune Checkpoint Inhibitor Treatment Outcomes and Body Composition Factors in Metastatic Renal Cell Carcinoma Patients
  14. A case of adrenal undifferentiated pleomorphic sarcoma with tertiary lymphoid structures responded to pembrolizumab
  15. A case of perirenal extra-adrenal myelolipoma mimicking liposarcoma
  16. A case of testicular torsion successfully treated with tunica albuginea incision and tunica vaginalis patch
  17. Editorial Comment to Novel quantitative software for automatically excluding red bone marrow on whole‐body magnetic resonance imaging in patients with metastatic prostate cancer: A pilot study
  18. The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma
  19. Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
  20. Editorial Comment to A regressed germ cell tumor discovered secondary to azoospermia
  21. Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava
  22. Abdominal wall abscess resembling urachal carcinoma caused by ileal diverticulitis
  23. A case of self-inserted foreign body in the urinary bladder: Usefulness of three-dimensional reconstruction computed tomography for surgery planning
  24. Efficacy of cabozantinib therapy for brain metastases from renal cell carcinoma
  25. A case of penile self‐mutilation during a suicidal attempt successfully treated using a multidisciplinary approach
  26. Editorial Comment to A case of sarcoidosis‐like reaction associated with immune checkpoint inhibitors in metastatic renal cell carcinoma
  27. A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
  28. Metastatic mucinous tubular and spindle cell carcinoma of the kidney responding to nivolumab plus ipilimumab
  29. A case of estrogen‐secreting adrenocortical carcinoma: Comprehensive immunohistochemical analysis of disorganized steroid genesis
  30. Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review
  31. Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non–muscle-invasive Bladder Cancer
  32. Combination of Cisplatin and Irradiation Induces Immunogenic Cell Death and Potentiates Postirradiation Anti–PD-1 Treatment Efficacy in Urothelial Carcinoma
  33. Spontaneous regression of multiple pulmonary metastases accompanied by normalization of serum immune markers following cytoreductive nephrectomy in a patient with clear‐cell renal cell carcinoma
  34. Utility of whole‐body diffusion‐weighted magnetic resonance imaging in the management of treatment‐related neuroendocrine prostate cancer
  35. Incidence and Risk Factors of Hypertension Following Partial Nephrectomy in Patients With Renal Tumors: A Cross-sectional Study of Postoperative Home Blood Pressure and Antihypertensive Medications
  36. Case of prostate stromal tumour of uncertain malignant potential where positron emission tomography with 18F-fluorodeoxyglucose was useful for surgical planning
  37. Immune-related myositis resulting from combination therapy of ipilimumab and nivolumab in patient with metastatic renal cell carcinoma
  38. Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy
  39. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer
  40. A case of recurrent thrombocytopenia involving divergent immune-related mechanisms associated with pembrolizumab
  41. Progressive Site-Directed Therapy for Castration-Resistant Prostate Cancer: Localization of the Progressive Site as a Prognostic Factor
  42. Renal function after bladder‐preserving therapy for patients with muscle‐invasive bladder cancer: Results of selective bladder‐preserving tetramodality therapy consisting of maximal transurethral resection, induction chemoradiotherapy and partial cyste...
  43. Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress
  44. Selective tetramodal bladder‐preservation therapy, incorporating induction chemoradiotherapy and consolidative partial cystectomy with pelvic lymph node dissection for muscle‐invasive bladder cancer: oncological and functional outcomes of 107 patients
  45. Clinical outcomes of muscle-invasive bladder cancer patients with hydronephrosis treated with tetra-modality bladder sparing therapy incorporating consolidative partial cystectomy.
  46. High levels of heat-shock factor 1 (HSF1) are associated with poor prognosis in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder sparing protocol
  47. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma
  48. Impact of Immunohistochemistry-Based Subtypes in Muscle-Invasive Bladder Cancer on Response to Chemoradiation Therapy
  49. Incidence and predictive factors of hypoglycemia after pheochromocytoma resection
  50. Acute kidney injury and intermediate-term renal function after clampless partial nephrectomy
  51. Computer-aided diagnosis of prostate cancer on magnetic resonance imaging using a convolutional neural network algorithm
  52. HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
  53. Clinical outcomes of patients with histologic variants of urothelial carcinoma treated with tetra-modality bladder-sparing protocol incorporating consolidative partial cystectomy.
  54. Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy
  55. Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction
  56. PD11-08 COMPUTER-AIDED DIAGNOSIS OF PROSTATE CANCER USING A DEEP NEURAL NETWORKS ALGORITHM IN PRE-BIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
  57. MP31-05 IMPACT OF BRAIN-TYPE NATRIURETIC PEPTIDE, A REPRESENTATIVE BIOMARKER FOR CARDIAC LOAD, ON NOCTURIA IN MEN.
  58. MP49-07 INCIDENCE AND RISK FACTORS OF POSTOPERATIVE HYPERTENSION AFTER PARTIAL NEPHRECTOMY FOR RENAL TUMORS
  59. MP15-04 NEW PREDICTIVE SCORING MODEL FOR RECURRENCE INCORPORATING BLADDER NECK INVOLVEMENT IN PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER CANCER
  60. MP71-15 PREDICTIVE ABILITY OF RENAL CORTEX ENHANCEMENT IN DYNAMIC CT FOR RESIDUAL RENAL FUNCTION AFTER NEPHROURETERECTOMY: COMPARATIVE STUDY WITH RENOGRAPHY
  61. MP57-12 SHORT-TERM ANDROGEN DEPRIVATION THERAPY INCREASES BRAIN-TYPE NATRIURETIC PEPTIDE LEVELS IN PATIENTS WITH PROSTATE CANCER: POSSIBLE ADVERSE IMPACT ON CARDIAC FUNCTION
  62. MP83-13 ZOLEDRONIC ACID SENSITIZES CASTRATION-RESISTANT PROSTATE CANCER CELLS TO RADIOTHERAPY AND CHEMOTHERAPY BY DOWNREGULATING STAT1
  63. Potential Utility of Diffusion-Weighted Magnetic Resonance Imaging in Diagnosis of Residual Bladder Cancer before Second Transurethral Resection
  64. Abstract 1288: Targeting the Hippo pathway in NF-2 deficient papillary kidney cancers
  65. MP24-18 FEASIBILITY OF NON-USE OF ANTIMICROBIAL PROPHYLAXIS IN MINIMALLY INVASIVE CLEAN SURGERY FOR RENAL OR ADRENAL TUMORS: A PROSPECTIVE STUDY OF 668 CASES
  66. Client Proteins and Small Molecule Inhibitors Display Distinct Binding Preferences for Constitutive and Stress-Induced HSP90 Isoforms and Their Conformationally Restricted Mutants
  67. Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas
  68. Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands
  69. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy
  70. New head-mounted display system applied to endoscopic management of upper urinary tract carcinomas
  71. Diagnostic performance and safety of a three-dimensional 14-core systematic biopsy method
  72. Head-Mounted Display for a Personal Integrated Image Monitoring System: Ureteral Stent Placement
  73. Clinical Application of a Modern High‐Definition Head‐Mounted Display in Sonography
  74. Pre-operative Risk Stratification for Cancer-specific Survival in Patients with Renal Cell Carcinoma with Venous Involvement Who Underwent Nephrectomy
  75. MP8-09 ANTIMICROBIAL PROPHYLAXIS IS AVOIDABLE IN MINIMALLY INVASIVE NEPHROURETERECTOMY WITH NEGATIVE URINE CULTURE
  76. MP69-08 BIOPSY GLEASON SCORE 3+4 MAY BE INCLUDED AS CRITERIA FOR ACTIVE SURVEILLANCE AFTER 2005 INTERNATIONAL SOCIETY OF UROLOGICAL PATHOLOGY CONSENSUS
  77. MP55-01 BLADDER-SPARING THERAPY IN MUSCLE-INVASIVE BLADDER CANCER BY INDUCTION CHEMORADIOTHERAPY PLUS PARTIAL CYSTECTOMY WITH PELVIC LYMPH NODE DISSECTION: ASSESSMENTS OF QUALITY OF LIFE AND URINARY FUNCTIONS
  78. MP7-09 DIFFUSION-WEIGHTED MRI FOR ASSESSING THE RESPONSE OF MUSCLE-INVASIVE BLADDER CANCER TO CHEMORADIOTHERAPY
  79. MP21-16 ERBB2 OVEREXPRESSION IS RELEVANT TO THERAPEUTIC RESISTANCE AND POOR PROGNOSIS IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH CHEMORADIATION-BASED BLADDER-SPARING PROTOCOL
  80. PD13-06 FAVORABLE OUTCOMES OF GASLESS SINGLE-PORT CLAMPLESS PARTIAL NEPHRECTOMY USING NEW THREE DIMENSIONAL HEAD-MOUNTED DISPLAY SYSTEM (ROBOSURGEON SYSTEM)
  81. MP67-08 IDENTIFICATION OF PATIENTS WHO CAN AVOID REPEAT BIOPSY USING MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING
  82. MP42-02 POTENTIAL OF ADDITIONAL MAGNETIC RESONANCE IMAGING (MRI)-TARGETED PROSTATE BIOPSY TO AVOID UNDERESTIMATION OF SYSTEMATIC 14-CORE BIOPSY
  83. OP1-12 REDUCED TRAP1 EXPRESSION IS ASSOCIATED WITH POOR PROGNOSIS IN UPPER URINARY TRACT UROTHELIAL CARCINOMA PATIENTS: ITS IMPLICATIONS FOR TUMOR INVASION
  84. MP55-09 SELECTIVE BLADDER-SPARING PROTOCOL CONSISTING OF INDUCTION LOW-DOSE CHEMORADIOTHERAPY AND CONSOLIDATIVE PARTIAL CYSTECTOMY IN MUSCLE INVASIVE BLADDER CANCER PATIENTS WITH SYNCHRONOUS OR METACHRONOUS MULTIFOCALITY
  85. Apparent diffusion coefficient value as a biomarker reflecting morphological and biological features of prostate cancer
  86. Usefulness of Pre-biopsy Multiparametric Magnetic Resonance Imaging and Clinical Variables to Reduce Initial Prostate Biopsy in Men with Suspected Clinically Localized Prostate Cancer
  87. Successful reduction of hospital-acquired methicillin-resistant Staphylococcus aureus in a urology ward: a 10-year study
  88. Zoledronic Acid Sensitizes Renal Cell Carcinoma Cells to Radiation by Downregulating STAT1
  89. 1468 POTENTIAL OF PREBIOPSY MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING TO REDUCE INITIAL BIOPSIES IN MEN WITH SUSPECTED CLINICALLY LOCALIZED PROSTATE CANCER
  90. 170 RADIOSENSITIZING EFFECT OF ZOLEDRONIC ACID ON RENAL CELL CARCINOMA CELLS BY DOWNREGULATING STAT1
  91. Antimicrobial Prophylaxis is Not Necessary in Clean Category Minimally Invasive Surgery for Renal and Adrenal Tumors: A Prospective Study of 373 Consecutive Patients
  92. 909 ANTIMICROBIAL PROPHYLAXIS IS NOT NECESSARY IN MINIMALLY INVASIVE PARTIAL NEPHRECTOMY WITHOUT ENTRY INTO THE URINARY TRACT
  93. 369 COMBINATION OF 14-CORE BIOPSY AND MAGNETIC RESONANCE IMAGING CAN IDENTIFY APPROPRIATE CANDIDATES FOR HEMIABLATIVE FOCAL THERAPY OF PROSTATE CANCER
  94. 56 SUCCESSFUL CONTROL OF METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS IN A UROLOGY WARD POSSIBLY DUE TO AVOIDANCE OF ANTIMICROBIAL PROPHYLAXIS IN MINIMALLY INVASIVE SURGERY: OUR 11 YEARS TRIAL
  95. Prostate‐specific antigen response to deferred combined androgen blockade therapy using bicalutamide predicts survival after subsequent oestrogen and docetaxel therapies in patients with castration‐resistant prostate cancer
  96. A case of metastatic testicular germ-cell tumor with rhabdomyosarcoma successfully treated with germ-cell tumor-oriented chemotherapy
  97. 1172 ANTIBIOTIC PROPHYLAXIS IS NOT NECESSARY IN MINIMALLY INVASIVE SURGERY FOR RENAL AND ADRENAL TUMORS: A PROSPECTIVE STUDY OF 301 CONSECUTIVE PATIENTS
  98. 1986 SENSITITIVITY TO CHEMORADIATION PREDICTS DEVELOPMENT OF METASTASIS IN MUSCLE-INVASIVE BLADDER CANCER PATIENTS
  99. 1092 IMPACT OF C-REACTIVE PROTEIN KINETICS ON SURVIVAL OF CASTRATION-RESISTANT PROSTATE CANCER PATIENTS TREATED WITH DOCETAXEL
  100. Feasibility of antegrade radical prostatectomy for clinically locally advanced prostate cancer: a comparative study with clinically localized disease
  101. 56 DIAGNOSTIC PERFORMANCE OF A THREE-DIMENSIONAL 14-CORE SYSTEMATIC BIOPSY WHICH CAN DETECT MORE THAN 95% OF THE PROSTATE CANCERS DETECTED BY THE THREE-DIMENSIONAL 26-CORE SUPER-EXTENDED BIOPSY SCHEME
  102. 897 DOCETAXEL IS EFFECTIVE TO ESTROGEN-REFRACTORY PROSTATE CANCER BUT NOT TO ESTROGEN- AND GLUCOCORTICOID-REFRACTORY PROSTATE CANCER
  103. 1636 PERFORMANCE OF FREE PSA BETTER THAN TOTAL PSA FOR ESTIMATION OF PROSTATE VOLUME IN ELDERLY MEN WITHOUT PROSTATE CANCER
  104. 16 THE IMPACT OF C-REACTIVE PROTEIN KINETICS ON SURVIVAL IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA TREATED WITH GEMCITABINE, ETOPOSIDE AND CISPLATIN
  105. A Novel Technique to Prevent Postradical Retropubic Prostatectomy Inguinal Hernia: The Processus Vaginalis Transection Method
  106. Simple prophylactic procedure of inguinal hernia after radical retropubic prostatectomy: Isolation of the spermatic cord
  107. NOVEL TECHNIQUE TO PREVENT POST-RADICAL RETROPUBIC PROSTATECTOMY INGUINAL HERNIA: THE PROCESSUS VAGINALIS TRANSECTION METHOD
  108. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate
  109. Lymphovascular invasion is an independent predictor of prostate‐specific antigen failure after radical prostatectomy in patients with pT3aN0 prostate cancer
  110. Lung and bone metastases from renal cell carcinoma responsive to bisphosphonates: A case report
  111. Ruthenium-catalyzed carbon–carbon formation to synthesize tetraarylethanes and tetraarylxylylene through dechlorinative dimeric reaction
  112. Synthesis and electrochemical properties of 1,1′-bis(benzo-1,3-dithiol-2-ylidene)ferrocene derivatives as novel electron donor compounds
  113. Intercalation and Pillaring of Layered Tantalate Photocatalysts
  114. Intercalation of Lithium and Iodine in the Ferroelectric Layered Compound Bi4Ti3O12−x
  115. Synthesis and Characterization of a New Layered Cuprate LiI3Bi2Sr2CaCu2O8
  116. Synthesis and Characterization of a New Layered Cuprate In2Ba2CuO6−δ
  117. Structure and Catalytic Property of Coherent Spinel Surface Layers on Hexaaluminate Microcrystals
  118. Stability Field of Layered Cuprate Ca1-xSrxCuO2 (x ∼ 0.1) at 1000°C under Oxygen Atmosphere
  119. Switched four-sector beam antenna for indoor wireless LAN systems in the 60 GHz band